Cas:99409-34-4 (2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane manufacturer & supplier

We serve Chemical Name:(2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane CAS:99409-34-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane

Chemical Name:(2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane
CAS.NO:99409-34-4
Synonyms:2,3,4-Tri-O-benzyl-1-S-ethyl-|A-L-thiofucopyranoside;2,3,4-Tri-O-benzyl-1-S-ethyl-L-thiofucopyranoside;W0117
Molecular Formula:C29H34O4S
Molecular Weight:478.64300
HS Code:

Physical and Chemical Properties:
Melting point:52-54ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:62.22000
Exact Mass:478.21800
LogP:6.24050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,3,4-Tri-O-benzyl-1-S-ethyl-|A-L-thiofucopyranoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,W0117 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3,4-Tri-O-benzyl-1-S-ethyl-|A-L-thiofucopyranoside Use and application,2,3,4-Tri-O-benzyl-1-S-ethyl-L-thiofucopyranoside technical grade,usp/ep/jp grade.


Related News: The insulin-only and bihormonal configurations may be helpful in diabetes. (2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane manufacturer A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan. (2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane supplier The insulin-only and bihormonal configurations may be helpful in diabetes. (2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane vendor During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. (2R,3S,4R,5R,6S)-2-ethylsulfanyl-6-methyl-3,4,5-tris(phenylmethoxy)oxane factory The insulin-only and bihormonal configurations may be helpful in diabetes.